Citigroup »

Allogene Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $110k 34k 3.21
2023-09-30 $1.1M 339k 3.18
2023-03-31 $2.7M 555k 4.94
2022-12-31 $2.2M 344k 6.29
2022-09-30 $5.7M 518k 11.01
2021-12-31 $3.7M 265k 13.79
2021-03-31 $4.4M 124k 35.30
2020-12-31 $570k 23k 25.25
2020-09-30 $406k 11k 37.69
2020-06-30 $2.1M 50k 42.88
2020-03-31 $887k 46k 19.45
2019-12-31 $1.2M 45k 26.00
2019-09-30 $1.2M 42k 27.25
2019-06-30 $2.5M 93k 26.85
2019-03-31 $112k 3.9k 28.71
2018-12-31 $152k 5.6k 27.01